IIB_osteosarcoma._Current_management_and_survival_statistics_in_the_USSR._Three_hundred_and_ninety-three_patients_with_IIB_osteosarcoma_were_treated_at_the_author's_institution_between_1955_and_1986._In_the_first_stage_of_the_study,_88_patients_were_treated_with_surgery_only._The_five-year_disease-free_survival_rate_was_7%._In_the_second_stage_of_the_study,_the_efficacy_of_preventive_chemotherapy_after_radical_surgery_was_studied_in_55_patients._The_five-year_disease-free_survival_rate_was_34.4%._In_the_third_stage_of_the_study,_the_efficacy_of_combination_therapy_consisting_of_preoperative_treatment,_limb-saving_surgery,_and_preventive_chemotherapy_was_studied_in_66_patients._The_five-year_disease-free_survival_rate_was_35.5%._The_authors_examined_results_in_21_patients_with_Grade_IV_responses_to_evaluate_the_relationship_between_prognosis_and_morphogenic_changes_after_preoperative_radiotherapy_and_chemotherapy._The_five-year_disease-free_survival_rate_was_57.9%._In_the_fourth_stage_of_the_study_(conducted_in_1986),_two_regimens_of_preoperative_chemotherapy_were_initiated._The_first_regimen_consists_of_intraarterial_platinum_infusions_to_patients_with_lower_extremity_bone_damage._The_second_regimen_consists_of_high-dose_methotrexate_infusions._The_preliminary_conclusion_is_that_primary_tumor_damage_is_significantly_more_marked_after_intraarterial_cisplatin_infusion.